The fixed-dose combination of pregabalin and duloxetine hydrochloride is mainly used in the treatment of neuropathic pain. Sensitive determination of drugs like pregabalin is challenging by chromatographic methods using UV detection due to their nonchromophoric nature. This study presents the development of a validated high-performance thin-layer chromatography (HPTLC) method for the simultaneous determination pregabalin and duloxetine hydrochloride in formulation. Because pregabalin has a weak chromophoric system, it was visualized using a derivatization reagent containing ninhydrin. Optimum separation of pregabalin and duloxetine hydrochloride was achieved on silica gel 60 F plates using methanol:dichloromethane:acetone:ammonia (8:1:1:0.2, v/v/v/v). Good resolution was achieved with R values of 0.34 ± 0.02 and 0.52 ± 0.02 for duloxetine hydrochloride and pregabalin, respectively. The method was validated as per the ICH Q2(R1) guidelines. Linearity range was found between 200 and 450 ng/band for duloxetine and 500 and 1125 ng/band for pregabalin. Low %RSD values shows that the developed method is precise. Greenness assessment of the developed method was evaluated using three different assessment tools, namely, Analytical Eco-Scale, GAPI, and AGREE This is the first validated derivatization-based HPTLC method for simultaneous analysis of duloxetine hydrochloride and pregabalin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/bmc.6078 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Differential Expression of tRNA-Derived Small RNA Markers of Antidepressant Response and Functional Forecast of Duloxetine in MDD Patients.
Genes (Basel)
January 2025
Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China.
Background/objectives: Duloxetine, despite being a leading treatment option for major depressive disorder (MDD), exhibits a relatively low adequate response rate when used as a monotherapy, and the fundamental molecular mechanisms remain largely elusive. tRNA-derived small RNA (tsRNA) is a particularly interesting and new class of molecules that is becoming increasingly noticeable for investigation.
Methods: We integrated small RNA sequencing with bioinformatics approaches to dissect the expression profiles of tsRNAs and decipher their functional roles post-duloxetine treatment.
Background: The objective of this study was to examine the characteristics of adverse drug reactions of duloxetine and investigate the potential precautions that may exist beyond the drug label.
Methods: This study used data from the Food and Drug Administration Adverse Event Reporting System database 2004-2023 and the linked information of duloxetine. Four algorithms used to evaluate the correlation between duloxetine and adverse events include reporting odds ratio, proportional reporting ratio, Bayesian confidence propagation neural network, and multi-item gamma Poisson shrinker.
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) for Treatment of Fibromyalgia: A Comprehensive Clinical Review.
Psychopharmacol Bull
February 2025
Hasoon, University of Texas Health Science Center at Houston, Department of Anesthesiology, Critical Care, and Pain Medicine, Houston, TX, USA.
Fibromyalgia is a complex clinical entity characterized by a broad range of symptoms including chronic widespread musculoskeletal pain, profound fatigue, impaired cognition, and mood disturbances. Current understanding of disease pathogenesis assumes neurotransmitter dysregulation and central pain sensitization play a key role resulting in heightened pain sensitivity. Genetic predisposition as well as alterations in endocrine and immune function have been implicated.
View Article and Find Full Text PDFBeneficial and harmful effects of duloxetine versus placebo, 'active placebo' or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
BMJ Open
February 2025
Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital ─ Rigshospitalet, Copenhagen, Denmark.
Objectives: To assess the beneficial and harmful effects of duloxetine versus 'active placebo', placebo or no intervention for adults with major depressive disorder.
Design: Systematic review with meta-analysis and trial sequential analysis of randomised trials.
Data Sources: Cochrane Central Register of Controlled Trials, MEDLINE, Embase, PsycINFO and other relevant databases up until January 2023.
Derivatization-Based Densitometric Approach Along With Greenness Assessment for Simultaneous Evaluation of Duloxetine Hydrochloride and Pregabalin: An Application to Pharmaceutical Analysis.
Biomed Chromatogr
March 2025
Department of Pharmaceutical Analysis, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences (Affiliated to Tamil Nadu Dr M.G.R. Medical University), Coimbatore, Tamil Nadu, India.
The fixed-dose combination of pregabalin and duloxetine hydrochloride is mainly used in the treatment of neuropathic pain. Sensitive determination of drugs like pregabalin is challenging by chromatographic methods using UV detection due to their nonchromophoric nature. This study presents the development of a validated high-performance thin-layer chromatography (HPTLC) method for the simultaneous determination pregabalin and duloxetine hydrochloride in formulation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!